Quote of the Day 💡
“People are always blaming their circumstances for what they are. The people who get on in this world are the people who get up and look for the circumstances they want, and if they cannot find them, make them.”
Carpe Diem: 10 Quick Sparks ⚡
Fast takes, curious stats, tiny epiphanies. Short enough to read between sips of coffee, potent enough to stay in your head all day.
- When AI Gets Crowded, Small Caps Get Interesting...
- When Policy Sneezes, Insurers Catch a Cold
- Traveling to L.A., Honolulu, San Francisco, or New York? Then Rent a…
- Trump renews demand for Greenland in Davos speech, but…
- With the Trump administration recently expanding its travel ban to 39 countries and...
- No Bulls? Just Bushes. 🌳🐻
- 🟡 Want Exposure to Bitcoin? A Director Bought Shares of…
- 🧠⚙️ When Cell Division Depends on Auto-Body Experience
- We'd Love To Go To Russia But...
- 💤 When Snoring’s Not… Sound — and Should Have You Worry
Latest Across FUNanc1al 📰🎢
Every fresh idea, stock story, travel twist, tech epiphany, and happiness insight we’ve shared recently — all in one stream.
- 🔗 Renaissance Technologies in 2025: Quant Quake, Post-Simons Growing Pains & The Limits of the Machine
- 🔗 CEO Purchases Abbott Shares, But the Stock Carries Risks
- 🔗 Principles of Prosperity: How Bridgewater’s AI-Driven “Machine” Built a Fortress in 2025
- 🔗 Le Relais de l’Entrecôte in Paris: Order Is Simple — and the Food Is Still Fun 🥩🍟
- 🔗 Cortisol, Addison’s Disease, and Why We Care
- 🔗 CEO and COO Buy Shares of RLI — Exceptionally Run Insurer, but Not Without Storm Clouds
- 🔗 Citadel’s 2025 Scorecard: No Fireworks, Just Relentless Discipline
- 🔗 Pancreatic Cancer: Panned by Critics — but Science Is Finally Fighting Back
- 🔗 CEO Buys More of This Warren Buffett Favorite: Ally Financial Is Up 30% Since Our Bullish Call — Buy More?
- 🔗 Quitting Obesity Drugs May Cut Costs — But Comes With Warnings & A Hidden Price Tag
- 🔗 No Bullish Trigger: Ginkgo Bioworks Should Read “Ginkgo Bio… Doesn’t Work”
- 🔗 How Exercise Neutralizes Muscle Loss — Biologically
- 🔗 Revisiting The Case of CRISPR Therapeutics: Still Crisp, Still Risky, Still Dangerously Alluring
- 🔗 Sports Revenue At Risk From Environmental Breakdowns
- 🔗 Ryan Cohen Buys More GameStop; Time to Play — or Make This Story Short?
- 🔗 The Competitive Landscape in Self-Driving Chips
- 🔗 Insider Buys Shares of Mainz Biomed: Promising Science, Precarious Finances
- 🔗 If Hair Gets Pulled Upward, Not Pushed Out: Perhaps the Bald Don’t Have Toupee the Same Price for Treatment?
- 🔗 Fundamental Research–Driven Fund Voss Capital Buys PAR Technology: Time to Shop?
- 🔗 Top Ten Incredible Things To Do in Florence, Italy
- 🔗 Funds Still Love Meta Platforms — Should Retail Add on Dips?
- 🔗 Laughing’s Health Benefits
- 🔗 Why Balance Predicts Longevity — And How To Improve It At Any Age
- 🔗 Director Buys Shares of Micron Technology: Should You?
- 🔗 John Rogers’ Ariel Investments Loves Madison Square Garden Entertainment: Should You?
- 🔗 5-Year Survival Rates for Cancer Are Rising: Let’s Keep It Up!
- 🔗 The Fashion Industry’s Challenges & Opportunities: Time to Embrace Human Rights, Climate Relief & More Good
- 🔗 Nvidia Is a Top-Five Stock Held by Hedge Funds: Should You Buy — or Even Hold?
- 🔗 Top Twenty Things to Do in Boston: Why the City Is So Worth Visiting 🧭🍀
- 🔗 Insiders Buy Airship AI; Should You Invest Or Just Do Surveillance?
- 🔗 Alzheimer’s: When the Disease Itself May Forget It Can Hurt — and Apoe-Logize
- 🔗 Goldman Sachs Loves Taiwan Semiconductor. Should You Buy This Taipei Investment?
- 🔗 Hedge Funds Like Royalty Pharma: Should Retail Wear the Crown?
- 🔗 Her, She, But You Better Nutella: The Health Benefits of Dark Chocolate
- 🔗 Hedge Funds Miller Value and Värde Partners Love Nabors Industries’ Cheap Shares, Deleveraging, and Saudi Aramco JV
Sponsored
Reserved for one sponsor per month. If this is you, let’s talk.
Spotlight Stories: Don’t Miss These 🔦
A short list of the posts we think are especially worth your time right now.
- Apple CEO & Nike Director Tim Cook Buys Shares: Is NKE Ready to Sprint?
- Ex-Morgan Stanley CEO Gorman Buys Disney: Time For Wonderland — or Better Questions?
- Moai, Gaman, and Shinrin-yoku: Japanese Pillars for Your Health
- Why I Miss The Hague So Much and Can’t Wait to Return
- LVMH’s Push Into Holistic Wellness Makes Sense: It's Tough To Sell To The Dead.
- Sweetgreen Update: When the CEO Buys the Salad Dip
- Listening to Music After 70 May Cut Dementia Risk by 40%, Playing by 35%, And Doing Both By Even More. 🎶 Sing Along If You Must.
- Pierre Hermé: Still Baking Some of the Best After All These Years
- Pepe’s: Still the Best Pizza After All These Years — and Yes, I’ve Been to Naples, Italy to Double-Check!
- The Odds of Dying a Particular Death Are Odd—And Guessing Them Even Odder
The Matrix 🧭
Pick your rabbit hole: finance, travel, health, tech, news, or hobbies. No wrong turns. Just FUN.
Sponsored
Reserved for one sponsor per month. If this is you, let’s talk.
Sponsored
Reserved for one sponsor per month. If this is you, let’s talk.
